-
Product Insights
NewContinuous Positive Airway Pressure (CPAP) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
CPAP Devices Pipeline Market Report Overview A continuous positive airway pressure machine (CPAP) is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. CPAP devices provide gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose that is connected to a nasal mask, nasal pillow, or a full-face mask. The CPAP devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sparsentan in Focal Segmental Glomerulosclerosis (FSGS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sparsentan in Focal Segmental Glomerulosclerosis (FSGS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sparsentan in Focal Segmental Glomerulosclerosis (FSGS) Drug Details: Sparsentan...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension Drug...
-
Sector Analysis
NewBusiness of the Golf Majors 2024 – Property Profile, Sponsorship and Media Landscape
Golf Majors 2024 Report Overview Golf is one of the most popular sports in the world and is enjoyed equally at both professional and personal levels. Many amateurs play regularly throughout the year making the sports popular at a recreational level. At a professional level, golf involves a huge amount of money. This, in turn, has made the elite players some of the most well-paid global athletes. The PGA Championship has the largest sponsorship inventory of ‘The Majors’ while ‘The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nilotinib in Acral Lentiginous Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nilotinib in Acral Lentiginous Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nilotinib in Acral Lentiginous Melanoma Drug Details: Nilotinib (Tasigna, AMN107)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Blinatumomab in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Blinatumomab in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Blinatumomab in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details: Blinatumomab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Blinatumomab in Lymphoblastic Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Blinatumomab in Lymphoblastic Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Blinatumomab in Lymphoblastic Lymphoma Drug Details: Blinatumomab (Blincyto) is a bi-specific monoclonal antibody...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Blinatumomab in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Blinatumomab in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Blinatumomab in Acute Lymphocytic Leukemia (ALL,...
-
Product Insights
NewCorneat Vision Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Corneat Vision Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Corneat Vision Ltd (Corneat Vision) an medical device company with an mission of promote human health, sustainability and equality. The company focuses to create groundbreaking solutions to unmet needs in the areas of ophthalmology and periodontology. The company is headquartered in Ra'anana, Israel. GlobalData's Medical Devices company profile report, “Corneat Vision Ltd Pipeline Insight and Competitive Landscape, 2023" provides...
-
Product Insights
Likelihood of Approval Analysis for Primary Progressive Multiple Sclerosis (PPMS)
Overview How likely is it that the drugs in Primary Progressive Multiple Sclerosis (PPMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Primary Progressive Multiple Sclerosis (PPMS) Overview Primary progressive multiple...